Acumen Research and Consulting recently published report titled “Alopecia Market Report and Region Forecast, 2022 – 2030”
LOS ANGELES, Dec. 29, 2022 (GLOBE NEWSWIRE) — The Global Alopecia Market Size accounted for USD 8,379 Million in 2021 and is estimated to achieve a market size of USD 16,760 Million by 2030 growing at a CAGR of 8.2% from 2022 to 2030.
Alopecia Market Statistics
- Global alopecia market revenue was worth USD 8,379 million in 2021, with a 8.2% CAGR from 2022 to 2030
- North America alopecia market share gathered more than 36.4% in 2021
- Asia-Pacific alopecia market growth is expected to expand at a CAGR of 6.7% from 2022 to 2030
- By distribution channel, the prescription category capture over 65.8% of total market share in 2021
- Increasing prevalence of areata and androgenic alopecia, propel the alopecia market value
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1286
Alopecia Market Report Coverage:
|Alopecia Market Size 2021||USD 8,379 Million|
|Alopecia Market Forecast 2030||USD 16,760 Million|
|Alopecia Market CAGR During 2022 – 2030||8.2%|
|Alopecia Market Analysis Period||2018 – 2030|
|Alopecia Market Base Year||2021|
|Alopecia Market Forecast Data||2022 – 2030|
|Segments Covered||By Disease Type, By Distribution Channel, By End Users, And By Geograph|
|Alopecia Market Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin – Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, and GlaxoSmithKline PLC.|
|Report Coverage||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Alopecia Market Overview
Alopecia also referred to as spot baldness, is a clinical syndrome characterized by loss of hair and bald patches on the scalp. Furthermore, sedentary lifestyles, poor eating habits, and rising stress levels are all contributing to excessive hair damage and loss. Alopecia areata is a common condition, with an estimated prevalence of one in every 1,000 people and a lifetime risk of about 2%.
Alopecia Market Trends
The rising prevalence of chronic diseases, increasing spending on healthcare and rising per capita income have all contributed to the market’s expansion. During the forecast period, topical has the largest market share. The greater absorbability as well as the non-invasive nature of treatments are driving growth. The treatments can be found in lotions, creams, and liquids. Men account for the majority of the alopecia market. Furthermore, the market for women is expected to grow during the forecast period. The primary driving force behind growth is a high level of awareness about hair treatments.
Some of the major driving factors for the market are the rising incidence of hair loss, technological innovations in alopecia diagnosis, and the increase in the number of chronic diseases associated with hair loss. Changing lifestyles, such as excessive alcohol and tobacco consumption, and rising stress indices among people, are thought to be major contributors to the rise in the prevalence of alopecia. Though the disease’s epidemiology is unidentified, genetic factors are thought to be one of the factors that cause and have been linked to many cases of alopecia. Furthermore, rising disposable income and a greater emphasis on aesthetics are expected to fuel demand for alopecia products. Furthermore, aging and genetic anomalies increase the demand for alopecia therapies. Ender also has a significant impact on disease receptivity.
Check the detailed table of contents of the report @
Alopecia Market Segmentation
The global alopecia market has been segmented by Acumen Research and Consulting based on disease type, distribution channel, and end users. By disease type, the segment is separated into alopecia areata, cicatricial alopecia, traction alopecia, alopecia totalis, androgenetic alopecia, alopecia universalis, and other. Alopecia Areata leads the segment, which is expected to grow at a healthy CAGR during the forecast period.
In terms of distribution channel, the market is categorized into prescriptions, and OTC. According to the alopecia market forecast, the alopecia areata category is predicted to develop significantly in the next years.
Moreover, the market is split into dermatology clinics, homecare settings, and other, based on the end users. Dermatology clinics will dominate the market during the forecast period. The major drivers responsible for dermatology clinics are newer technologies and appropriate medication or therapy.
Alopecia Market Regional Overview
Based on the region, the worldwide alopecia market segmentation is into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to an alopecia industry analysis, North America holds the largest market share in 2021. The introduction of brand-new drugs, as well as favorable activities undertaken by relevant organizations, are the primary motivators for the region’s significant chunk. The presence of large numbers of players, the existence of major market players, as well as the availability of substantial investments will all contribute to market growth. Due to its well-developed healthcare industry, large aging population, as well as high spending on healthcare, the United States controls the majority of the market. Europe is the market’s second biggest region, followed by Asia-Pacific. During the projected timeline, Asia-Pacific is predicted to expand at the fastest rate. Over the projected timeframe, nations such as China, India, and Singapore will present significant opportunities for growth due to economic development and rising disposable income.
Buy this premium research report –
Alopecia Market Players
Some of the prominent alopecia market companies are Dr. Reddy’s Laboratories Ltd, Cipla, Lexington International LLC, Viviscal, Regaine, Kirkland Signature, Alpecin – Dr. Kurt Wolff GmbH & Co, Vitabiotics, Johnson and Johnson, Merck & Co., Ranbaxy Laboratories Ltd, and GlaxoSmithKline PLC.
Questions Answered By This Report
- What was the market size of Alopecia Market in 2021?
- What will be the CAGR of Alopecia Market during the forecast period from 2022 to 2030?
- Who are the major players in Global Alopecia Market?
- Which region held the largest share in Alopecia Market in 2021?
- What are the key market drivers of Alopecia Market?
- Who is the largest end user Alopecia Market?
- What will be the Alopecia Market value in 2030?
Browse More Research Topic on Healthcare Sector Related Reports:
The Global Veterinary Services Market size accounted for USD 99.5 Billion in 2021 and is expected to reach USD 162.5 Billion by 2030 growing at a CAGR of 5.8% during the forecast timeframe from 2022 to 2030.
The Global Mussel Oil & Powder Market size accounted for USD 166 Million in 2021 and is estimated to reach USD 258 Million by 2030.
The Global Healthcare Smart Beds Market size accounted for USD 561 Million in 2021 and is estimated to reach USD 1,166 Million by 2030.
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter , Instagram and LinkedIn
Mr. Richard Johnson
Acumen Research and Consulting
E-mail: [email protected]